Article Dans Une Revue EFSA Journal Année : 2023

Re‐evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs

Claude Lambré
  • Fonction : Auteur
José Manuel Barat Baviera
  • Fonction : Auteur
Riccardo Crebelli
  • Fonction : Auteur
David Michael Gott
  • Fonction : Auteur
Konrad Grob
  • Fonction : Auteur
Evgenia Lampi
  • Fonction : Auteur
Alicja Mortensen
  • Fonction : Auteur
Inger‐lise Steffensen
  • Fonction : Auteur
Christina Tlustos
  • Fonction : Auteur
Holger Zorn
  • Fonction : Auteur
Monika Batke
  • Fonction : Auteur
Margherita Bignami
  • Fonction : Auteur
Ursula Gundert‐remy
  • Fonction : Auteur
Thorhallur Halldorsson
  • Fonction : Auteur
Andrew Hart
  • Fonction : Auteur
Evangelia Ntzani
  • Fonction : Auteur
Eugenio Scanziani
  • Fonction : Auteur
Henri Schroeder
  • Fonction : Auteur
Beate Ulbrich
  • Fonction : Auteur
Dina Waalkens‐berendsen
  • Fonction : Auteur
Detlef Woelfle
  • Fonction : Auteur
Zainab Al Harraq
  • Fonction : Auteur
Katleen Baert
  • Fonction : Auteur
Maria Carfì
  • Fonction : Auteur
Anna Castoldi
  • Fonction : Auteur
Cristina Croera
  • Fonction : Auteur
Henk van Loveren
  • Fonction : Auteur

Résumé

In 2015, EFSA established a temporary tolerable daily intake (t-TDI) for BPA of 4 μg/kg body weight (bw) per day. In 2016, the European Commission mandated EFSA to re-evaluate the risks to public health from the presence of BPA in foodstuffs and to establish a tolerable daily intake (TDI). For this re-evaluation, a pre-established protocol was used that had undergone public consultation. The CEP Panel concluded that it is Unlikely to Very Unlikely that BPA presents a genotoxic hazard through a direct mechanism. Taking into consideration the evidence from animal data and support from human observational studies, the immune system was identified as most sensitive to BPA exposure. An effect on Th17 cells in mice was identified as the critical effect; these cells are pivotal in cellular immune mechanisms and involved in the development of inflammatory conditions, including autoimmunity and lung inflammation. A reference point (RP) of 8.2 ng/kg bw per day, expressed as human equivalent dose, was identified for the critical effect. Uncertainty analysis assessed a probability of 57–73% that the lowest estimated Benchmark Dose (BMD) for other health effects was below the RP based on Th17 cells. In view of this, the CEP Panel judged that an additional uncertainty factor (UF) of 2 was needed for establishing the TDI. Applying an overall UF of 50 to the RP, a TDI of 0.2 ng BPA/kg bw per day was established. Comparison of this TDI with the dietary exposure estimates from the 2015 EFSA opinion showed that both the mean and the 95th percentile dietary exposures in all age groups exceeded the TDI by two to three orders of magnitude. Even considering the uncertainty in the exposure assessment, the exceedance being so large, the CEP Panel concluded that there is a health concern from dietary BPA exposure.

Domaines

Dates et versions

hal-04346948 , version 1 (15-12-2023)

Identifiants

Citer

Claude Lambré, José Manuel Barat Baviera, Claudia Bolognesi, Andrew Chesson, Pier Sandro Cocconcelli, et al.. Re‐evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA Journal, 2023, 21 (4), ⟨10.2903/j.efsa.2023.6857⟩. ⟨hal-04346948⟩
80 Consultations
0 Téléchargements

Altmetric

Partager

  • More